Enoxi Injection contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) used to prevent and treat blood clots (thrombosis). It is commonly prescribed for deep vein thrombosis (DVT), pulmonary embolism (PE), and clot prevention after surgeries or in bedridden patients. It also helps reduce the risk of complications in patients with unstable angina or certain types of heart attacks.
---
Dosage (General Use):
Dosage depends on condition and patient’s weight.
For DVT prevention: 20–40 mg once daily subcutaneously.
For treatment of DVT/PE: 1 mg/kg every 12 hours or 1.5 mg/kg once daily subcutaneously.
Administered by subcutaneous injection, usually in the abdomen.
(Use exactly as prescribed by a healthcare provider.)
---
Precautions & Warnings:
Not for intramuscular injection.
Use with caution in patients with bleeding disorders, kidney disease, recent surgery, or stomach ulcers.
May interact with other anticoagulants, aspirin, or NSAIDs.
Regular monitoring of blood clotting parameters may be required.
Pregnant or breastfeeding women should use only if prescribed.
Avoid activities that increase bleeding risk (contact sports, sharp objects).
---
Possible Side Effects:
Pain, redness, or bruising at injection site.
Bleeding gums, nosebleeds, or unusual bleeding.
Low platelet count (thrombocytopenia).
Rare: severe allergic reaction, spinal/epidural hematoma (if given with spinal anesthesia).